Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review

May 2021 | 71 pages | ID: SE5EBDCFFE0EN
GlobalData

Abstracts

Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sino Biopharmaceutical Ltd (Sino Biopharma), a subsidiary of CP Pharmaceutical Group, is a research driven pharmaceutical company that develops, manufactures, and markets chemical medicines, biopharmaceuticals, and Chinese medicines. It offers medicines for the treatment of hepatitis, cardio-cerebral diseases, cancer, orthopedic diseases, infectious diseases, and respiratory and digestive diseases, among others. The company offers products in various dosage forms including large volume injections, PVC-free soft bags for intravenous injections, small volume injections, powdered medicines, granulated medicines, capsules, and tablets. It works in partnership with several domestic and foreign pharmaceutical companies to advance the development of its products. Sino Biopharma is headquartered in Beijing, China.

Sino Biopharmaceutical Ltd Key Recent Developments

May 10,2021: Sino Biopharmaceutical announces appointment of Chief Medical Officer
Feb 26,2021: Sino Biopharmaceutical announces change of address of share registrar and transfer agent in the Cayman Islands
Dec 31,2020: Sino Biopharmaceutical: Appointment of independent non-executive director
Nov 30,2020: Sino Biopharmaceutical announces 2020 third quarterly results
Aug 28,2020: Sino Biopharm announces 2020 interim results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Sino Biopharmaceutical Ltd - Key Facts
Sino Biopharmaceutical Ltd - Key Employees
Sino Biopharmaceutical Ltd - Key Employee Biographies
Sino Biopharmaceutical Ltd - Major Products and Services
Sino Biopharmaceutical Ltd - History
Sino Biopharmaceutical Ltd - Company Statement
Sino Biopharmaceutical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sino Biopharmaceutical Ltd - Business Description
Product Category: Anti-Infectious Medicines
Overview
Performance
Product Category: Hepatitis Medicines
Overview
Performance
Product Category: Oncology Medicines
Overview
Performance
Product Category: Orthopedic Medicines
Overview
Performance
Product Category: Others
Overview
Performance
Product Category: Respiratory System Medicines
Overview
Performance
R&D Overview
Sino Biopharmaceutical Ltd - Corporate Strategy
Sino Biopharmaceutical Ltd - SWOT Analysis
SWOT Analysis - Overview
Sino Biopharmaceutical Ltd - Strengths
Sino Biopharmaceutical Ltd - Weaknesses
Sino Biopharmaceutical Ltd - Opportunities
Sino Biopharmaceutical Ltd - Threats
Sino Biopharmaceutical Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sino Biopharmaceutical Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 10, 2021: Sino Biopharmaceutical announces appointment of Chief Medical Officer
Feb 26, 2021: Sino Biopharmaceutical announces change of address of share registrar and transfer agent in the Cayman Islands
Dec 31, 2020: Sino Biopharmaceutical: Appointment of independent non-executive director
Nov 30, 2020: Sino Biopharmaceutical announces 2020 third quarterly results
Aug 28, 2020: Sino Biopharm announces 2020 interim results
Aug 20, 2020: Sino Biopharmaceutical: Announces board changes
Aug 19, 2020: Sino Biopharmaceutical : Appointment of Executive Director, redesignation of Director and change of Chief Executive Officer
May 28, 2020: Sino Biopharmaceutical announces 2020 first quarterly results
Mar 30, 2020: Sino Biopharm announces 2019 annual results
Feb 19, 2020: KWM advises on Sino Biopharmaceutical’s €750 million convertible bonds

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sino Biopharmaceutical Ltd, Key Facts
Sino Biopharmaceutical Ltd, Key Employees
Sino Biopharmaceutical Ltd, Key Employee Biographies
Sino Biopharmaceutical Ltd, Major Products and Services
Sino Biopharmaceutical Ltd, History
Sino Biopharmaceutical Ltd, Other Locations
Sino Biopharmaceutical Ltd, Subsidiaries
Sino Biopharmaceutical Ltd, Key Competitors
Sino Biopharmaceutical Ltd, Ratios based on current share price
Sino Biopharmaceutical Ltd, Annual Ratios
Sino Biopharmaceutical Ltd, Annual Ratios (Cont...1)
Sino Biopharmaceutical Ltd, Annual Ratios (Cont...2)
Sino Biopharmaceutical Ltd, Interim Ratios
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sino Biopharmaceutical Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Sino Biopharmaceutical Ltd, Performance Chart (2016 - 2020)
Sino Biopharmaceutical Ltd, Ratio Charts
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021